|
Inmed Pharmaceuticals Inc (NASDAQ: INM) |
|
Inmed Pharmaceuticals Inc
INM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Inmed Pharmaceuticals Inc growth rates, revenue grew
by 145.68 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 702
Major Pharmaceutical Preparations industry recorded
growth of revenues by 10.23 %
Inmed Pharmaceuticals Inc net loss decreased from $-8 millions, to $-2 millions in I. Quarter 2024,
• More on INM's Growth
|
|
Inmed Pharmaceuticals Inc realized a net loss in trailing twelve months.
Inmed Pharmaceuticals Inc realized cash reduction of $ -34.11 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on INM's Valuation
|
|
|
|
|
Inmed Pharmaceuticals Inc realized net loss in trailing twelve months.
Inmed Pharmaceuticals Inc realized cash outflow of $ -34.11per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Inmed Pharmaceuticals Inc Price to Book Ratio is at 0.01 lower than Industry Avg. of 79.76. and equal to S&P 500 Avg. of 0.01
• More on INM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com